Image Source: Zacks Investment Research Headwinds for Penumbra Foreign Exchange Impacts Sales: A significant portion of Penumbra’s sales and costs is exposed to changes in foreign exchange rates.

Veteran medical device maker Penumbra(NYSE: PEN) got a shot of good news on Wednesday. An analyst initiated coverage of the company's stock with a rather bullish review, and investors took this to ...

Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, and Asahi Intecc Co., a leading Japanese medical device manufacturer, announced that they will collaborate ...

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced that its RED ® Reperfusion Catheters have secured CE Mark (Conformité Européenne) and are now ...